Hap Trading, LLC Novo Cure LTD Call Options Transaction History

Hap Trading, LLC

$872 Billion
Q3 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	SELL	$15.61 - $23.34 $9,366 - $14,004	-600 Reduced 5.22%	10,900 $1.12 Million
Q2 2024 Aug 14, 2024	SELL	$11.83 - $24.05 $1.59 Million - $3.24 Million	-134,800 Reduced 92.14%	11,500 $4.05 Million
Q1 2024 May 13, 2024	BUY	$12.42 - $17.29 $1.33 Million - $1.85 Million	106,800 Added 270.38%	146,300 $16.3 Million
Q4 2023 Feb 14, 2024	SELL	$11.13 - $15.78 $12,243 - $17,358	-1,100 Reduced 2.71%	39,500 $12.3 Million
Q3 2023 Nov 09, 2023	BUY	$16.15 - $42.35 $655,690 - $1.72 Million	40,600 New	40,600 $655,000
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $44,786 - $59,759	700 Added 3.21%	22,500 $79,000
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $258,361 - $340,366	3,800 Added 21.11%	21,800 $54,000
Q2 2022 Aug 12, 2022	SELL	$56.6 - $89.9 $158,480 - $251,720	-2,800 Reduced 13.46%	18,000 $46,000
Q1 2022 May 12, 2022	SELL	$60.15 - $84.52 $619,545 - $870,556	-10,300 Reduced 33.12%	20,800 $110,000
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $540,576 - $878,328	7,200 Added 30.13%	31,100 $111,000
Q3 2021 Nov 10, 2021	BUY	$116.17 - $194.55 $81,319 - $136,185	700 Added 3.02%	23,900 $216,000
Q2 2021 Aug 11, 2021	BUY	$130.4 - $225.58 $1.81 Million - $3.14 Million	13,900 Added 149.46%	23,200 $1.15 Million
Q1 2021 May 14, 2021	SELL	$124.11 - $190.17 $893,592 - $1.37 Million	-7,200 Reduced 43.64%	9,300 $216,000
Q4 2020 Feb 16, 2021	SELL	$112.16 - $174.14 $1.36 Million - $2.11 Million	-12,100 Reduced 42.31%	16,500 $1.02 Million
Q3 2020 Nov 13, 2020	BUY	$58.05 - $111.31 $1.66 Million - $3.18 Million	28,600 New	28,600 $711,000
Q1 2020 May 08, 2020	SELL	$57.05 - $95.75 $1.24 Million - $2.08 Million	-21,700 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$68.3 - $93.8 $457,610 - $628,460	-6,700 Reduced 23.59%	21,700 $131,000
Q3 2019 Nov 12, 2019	BUY	$61.86 - $97.8 $1.76 Million - $2.78 Million	28,400 New	28,400 $236,000
Q4 2018 Feb 12, 2019	SELL	$28.72 - $52.63 $890,320 - $1.63 Million	-31,000 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$32.0 - $52.4 $480,000 - $786,000	15,000 Added 93.75%	31,000 $567,000
Q2 2018 Aug 13, 2018	BUY	$19.85 - $32.0 $317,600 - $512,000	16,000 New	16,000 $36,000

Others Institutions Holding NVCR

# of Institutions

263

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$374 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$365 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$244 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$133 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$93.3 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account